Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Heba Sheha
Evaluation of Different Treatment Regimens for Relapsed and Refractory NHL: Single Institute Experience
Journal of Cancer Therapy
Related publications
Salvage Treatment for Refractory or Relapsed Acute Myeloid Leukemia: A 10-Year Single-Center Experience
Clinics
Medicine
Venetoclax (Ven) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Nelarabine Treatment in Adult Patients With Refractory/ Relapsed T-Cell Acute Lymphoblastic Leukaemia/Lymphoma: Experience of a Single Centre
Gematologiya i Transfuziologiya
Hematology
Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Annals of Hematology
Medicine
Hematology
Treatment of Relapsed and Refractory T-Cell Lymphomas: First Pavlov State Medical University of Saint-Petersburg Experience
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Treatment of Refractory and Relapsed Hodgkin's Lymphoma: Facts and Perspectives
Haematologica
Hematology
